MB

Madhu Bhatnagar

Active Director Director DIN 03350211
DIN 03350211 First appointment Feb 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2004
Shareholding value •••• Premium profile

About Madhu Bhatnagar

Data last updated:

Madhu Bhatnagar is a Director at Rashi Pharmaceuticals Private Limited (since 2004). The company operates in Healthcare. Rashi Pharmaceuticals Private Limited reported revenue of ₹87.1 Lakh (FY 2025).

DIN 03350211
Primary Designation Director
Industry Healthcare
First Appointment 13 Feb 2004
Oldest Company Age 22 yrs
Largest company Rashi Pharmaceuticals Private Limited · ₹87.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20042004₹87.1 Lakh (FY 2025)Active

Board colleagues of Madhu Bhatnagar

Directorship timeline

Open interactive timeline →
Rashi Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Madhu Bhatnagar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Madhu Bhatnagar

Madhu Bhatnagar currently holds 1 directorship: Rashi Pharmaceuticals Private Limited (Director, since 13 Feb 2004, revenue ₹87.1 Lakh (FY 2025)).

Madhu Bhatnagar was first appointed on 13 Feb 2004 as Director at Rashi Pharmaceuticals Private Limited.

The current boards of Madhu Bhatnagar's companies include Mahesh Singh Bhatnagar (Rashi Pharmaceuticals Private Limited), Rana Bhatnagar (Rashi Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available